AGP Executive Report
Last update: 3 hours agoHemp Business: UK wellness brand HempWell secured a phased multi-million-pound investment from fitness and recovery brand JJ Double Gold, backing expanded production and growth into mental health, women’s health, sports performance and recovery. Health & Research: Oregon’s updated cannabis review cites evidence for pharmaceutical cannabinoids such as CBD in treating seizure disorders and chemotherapy-related nausea, while also highlighting health risks. A separate review finds evidence for cannabis as an insomnia treatment remains mixed. Regulatory Pressure: U.S. hemp retailers and businesses face uncertainty from a looming federal hemp ban, with Chicago businesses bracing for cleared shelves and a December deadline drawing attention from convenience retailers. Global Markets: MediPharm Labs launched an ANVISA-authorized cannabis extract oil commercially in Brazil, extending its international reach. Policy Outlook: Incoming Republican leaders oppose marijuana reform as the Trump administration moves ahead with rescheduling, leaving the regulatory outlook uncertain for CBD and cannabis businesses.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
